CYH / Community Health Systems, Inc. (NYSE) - Forecast, Price Target, Estimates, Predictions

Community Health Systems, Inc.
US ˙ NYSE ˙ US2036681086

Projected Stock Price
$3.50 ↑20.06%

Estimated share price by September 2, 2026.

Projected Revenue

3,553  MM ↑13.41%

Estimated quarterly revenue by December 31, 2026.

Projected Earnings Per Share

0.46 ↓-77.96%

Estimated quarterly earnings by December 31, 2026.

Price Target

The average one-year price target for Community Health Systems, Inc. is $3.50. The forecasts range from a low of $2.52 to a high of $5.25.

Update Frequency: Monthly

Record Date Projection Date High Low Median Average
2025-09-02 2026-09-02 5.25 2.52 3.29 3.50
Stock Upgrades/Downgrades

This card shows analyst upgrades/downgrades for Community Health Systems, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.

The standard analyst ratings are generally as follows:
  • Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
  • Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
  • Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.

When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.

The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.

Why Are Analyst Ratings important?

In addition to being able to interpret financial data, stock analysts have connections within the companies they cover that give them access to information retail investors do not have.

Therefore, analyst ratings can help you find opportunities in the market. However, they are guidelines more than recommendations. This is why it’s important to look at analyst ratings over a period of time.

If analysts change their ratings frequently, you should pay close attention to the company’s fundamentals. For example, has there been a significant change to the company’s earnings growth and/or debt?

You should also pay attention to the number of analysts covering a stock over the course of a year. In general, the more analysts who cover the stock give the consensus rating more credibility, but each individual rating less overall weight.

How to Use Analyst Ratings ?

Analyst ratings are one data point for you to consider. Here are some strategies you can use to fine tune your research.

Look at more than one analyst and don’t hesitate to look at analysts that have differing views. This can help challenge any preconceived ideas you have about a stock and point out ways in which your thesis for owning or avoiding a stock may have changed.

Compare a stock’s rating with other stocks in its industry or sector. In some cases, a stock is simply superior to others in its sector. However, at other times, it could be overvalued based on investor sentiment instead of fundamentals.

How are the Fintel Analyst Ratings different?

Analyst ratings by Fintel are presented in close to real-time to stay ahead of generalized information flow. Combined with target price estimates and revenue estimates for the company you have greater accuracy despite market volatility.

Date Analyst Prior Latest
Recommendation
Action
2023-01-03 Wells Fargo Equal-Weight Maintains
2023-01-19 Oppenheimer Outperform Maintains
2022-11-23 Credit Suisse Neutral Maintains
2022-08-01 Credit Suisse Neutral Maintains
2022-07-29 Oppenheimer Outperform Maintains
2022-06-17 Loop Capital Hold Initiate
2022-06-15 B of A Securities Buy Neutral Downgrade
2022-05-02 Wells Fargo Equal-Weight Maintains
2022-04-29 RBC Capital Outperform Maintains
2022-04-29 Citigroup Buy Maintains
2022-03-29 Wells Fargo Equal-Weight Initiate
2021-12-13 B of A Securities Underperform Buy Upgrade
2021-10-29 Credit Suisse Neutral Maintains
2021-09-24 UBS Neutral Initiate
2021-08-03 Barclays Underweight Maintains
2021-07-30 Credit Suisse Neutral Maintains
2021-07-09 Seaport Global Neutral Initiate
2021-06-10 RBC Capital Sector Perform Outperform Upgrade
2021-05-05 Jefferies Hold Buy Upgrade
2021-04-30 Credit Suisse Underperform Neutral Upgrade
2021-02-19 Credit Suisse Underperform Maintains
2020-05-04 Oppenheimer Outperform Maintains
2020-02-20 Raymond James Underperform Market Perform Upgrade
2020-02-20 B of A Securities Underperform Maintains
2019-12-18 SunTrust Robinson Humphrey Hold Maintains
2018-10-31 Cantor Fitzgerald Neutral Neutral Maintains
2018-08-16 Morgan Stanley Underweight Underweight Maintains
2018-08-14 Barclays Underweight Initiate
2018-07-30 Baird Neutral Neutral Maintains
2018-07-27 Bank of America Underperform Underperform Maintains
2018-07-13 Morgan Stanley Underweight Underweight Maintains
2018-01-03 Goldman Sachs Sell Initiate
2017-12-14 JP Morgan Neutral Underweight Downgrade
2017-11-03 Morgan Stanley Underweight Maintains
2017-11-03 Citigroup Neutral Maintains
2017-11-02 Credit Suisse Underperform Initiate
2017-08-03 Deutsche Bank Hold Maintains
2017-06-07 Morgan Stanley Underweight Initiate
2017-04-05 Deutsche Bank Hold Initiate
2017-03-01 PiperJaffray Neutral Underweight Downgrade
2017-02-22 Baird Underperform Neutral Upgrade
2017-02-21 Mizuho Underperform Neutral Upgrade
2017-01-04 PiperJaffray Neutral Initiate
2016-11-11 Credit Suisse Neutral Underperform Downgrade
2016-10-27 Mizuho Neutral Underperform Downgrade
2016-10-27 Baird Neutral Underperform Downgrade
2016-10-24 Wolfe Research Peer Perform Initiate
2016-09-30 Citigroup Neutral Maintains
2016-09-14 Susquehanna Neutral Positive Upgrade
2016-08-12 Mizuho Underperform Neutral Upgrade
2016-08-09 Leerink Swann Outperform Market Perform Downgrade
2016-08-05 Citigroup Neutral Maintains
2016-08-04 Barclays Equal-Weight Maintains
2016-08-03 UBS Buy Neutral Downgrade
2016-07-29 Credit Suisse Neutral Initiate
2016-05-24 Morgan Stanley Underweight Downgrade
2016-05-04 Leerink Swann Market Perform Outperform Upgrade
2016-05-03 Bank of America Neutral Underperform Downgrade
2016-04-25 Raymond James Market Perform Underperform Downgrade
2016-02-17 Oppenheimer Outperform Maintains
2016-02-17 Barclays Equal-Weight Maintains
2016-02-16 SunTrust Robinson Humphrey Buy Neutral Downgrade
2016-02-16 Mizuho Neutral Underperform Downgrade
2016-02-16 Jefferies Buy Hold Downgrade
2016-02-16 Avondale Partners Market Outperform Market Perform Downgrade
2016-01-28 Raymond James Underperform Market Perform Upgrade
2016-01-08 Wedbush Outperform Neutral Downgrade
2016-01-06 Raymond James Market Perform Underperform Downgrade
2016-01-06 Barclays Equal-Weight Maintains
2016-01-04 Wells Fargo Outperform Market Perform Downgrade
2015-10-27 Leerink Swann Outperform Market Perform Downgrade
2015-10-26 Baird Outperform Neutral Downgrade
2015-10-22 Susquehanna Positive Neutral Downgrade
2015-10-22 Raymond James Market Perform Outperform Downgrade
2015-10-22 Mizuho Buy Neutral Downgrade
2015-10-22 Bank of America Buy Neutral Downgrade
2015-10-08 Barclays Equal-Weight Maintains
2015-09-16 JP Morgan Neutral Initiate
2015-08-24 Mizuho Buy Maintains
2015-08-13 Raymond James Market Perform Outperform Upgrade
2015-08-05 Jefferies Buy Maintains
2015-07-16 KeyBanc Overweight Downgrade
2015-06-29 Mizuho Neutral Buy Upgrade
2015-06-26 Wells Fargo Market Perform Outperform Upgrade
2015-06-26 Raymond James Outperform Market Perform Downgrade
2015-06-26 Oppenheimer Outperform Maintains
2015-06-26 Mizuho Neutral Buy Upgrade
2015-06-26 Jefferies Buy Maintains
2015-06-10 Wedbush Outperform Initiate
2015-01-08 Credit Suisse Outperform Maintains
2014-12-18 Sterne Agee Buy Initiate
2014-11-12 Wells Fargo Outperform Market Perform Downgrade
2014-11-05 Barclays Equal-Weight Maintains
2014-11-04 Credit Suisse Outperform Maintains
2014-10-02 KeyBanc Buy Maintains
2014-09-09 Deutsche Bank Buy Maintains
2014-08-05 Credit Suisse Outperform Maintains
2014-08-05 Citigroup Neutral Maintains
2014-08-04 Cantor Fitzgerald Hold Maintains
2014-08-04 Barclays Equal-Weight Maintains
2014-08-01 Jefferies Buy Maintains
2014-06-26 KeyBanc Buy Maintains
2014-06-03 JP Morgan Overweight Maintains
2014-05-19 Cantor Fitzgerald Hold Maintains
2014-05-12 BMO Capital Market Perform Maintains
2014-05-08 FBR Capital Outperform Maintains
2014-05-08 Barclays Equal-Weight Maintains
2014-04-14 Oppenheimer Market Perform Outperform Upgrade
2014-03-31 Monness Crespi Hardt Buy Initiate
2014-03-10 JP Morgan Overweight Maintains
2014-01-07 Deutsche Bank Buy Maintains
2013-10-07 Deutsche Bank Buy Maintains
2013-09-09 Citigroup Buy Neutral Downgrade
2013-07-22 Deutsche Bank Buy Maintains
2013-07-11 KeyBanc Buy Initiate
2013-06-12 Deutsche Bank Hold Buy Upgrade
2013-04-29 UBS Buy Maintains
2013-04-23 Baird Neutral Outperform Upgrade
2013-04-10 Deutsche Bank Buy Hold Downgrade
2013-03-27 BMO Capital Underperform Market Perform Upgrade
2013-03-25 JP Morgan Overweight Maintains
2013-03-18 Jefferies Hold Buy Upgrade
2013-02-26 BMO Capital Underperform Maintains
2013-02-25 UBS Buy Maintains
2013-02-25 Morgan Stanley Overweight Maintains
2013-02-11 BMO Capital Market Perform Underperform Downgrade
2013-01-30 Deutsche Bank Buy Maintains
2013-01-25 UBS Buy Maintains
2013-01-17 Morgan Stanley Overweight Initiate
2013-01-11 Bank of America Neutral Buy Upgrade
2012-12-18 JP Morgan Overweight Initiate
2012-11-26 Baird Outperform Neutral Downgrade
2012-11-12 Imperial Capital Outperform Maintains
2012-10-11 Barclays Equal-Weight Initiate
2012-10-08 Jefferies Hold Maintains
2012-07-26 Cantor Fitzgerald Hold Maintains
2012-07-02 Bank of America Neutral Maintains
2012-06-29 Wells Fargo Outperform Upgrade
2012-05-01 Goldman Sachs Neutral Upgrade
2012-04-27 Jefferies Hold Maintains
2012-04-27 Bank of America Neutral Maintains
2012-03-09 Cantor Fitzgerald Hold Initiate
2012-03-06 Jefferies Hold Maintains
2012-02-23 Deutsche Bank Buy Upgrade
2012-02-23 Citigroup Neutral Maintains
2012-02-22 Bank of America Neutral Maintains
2012-02-22 Auriga Hold Maintains
2023-02-17 Credit Suisse Neutral Maintains
2023-05-02 Oppenheimer Outperform Reiterate
2023-05-03 RBC Capital Outperform Maintains
2023-05-03 Credit Suisse Neutral Maintains
2023-05-03 Wells Fargo Equal-Weight Maintains
2023-05-03 Citigroup Buy Maintains
2023-10-11 Truist Securities Hold Hold Maintains
2023-10-30 RBC Capital Outperform Outperform Maintains
2023-06-20 Truist Securities Hold Hold Maintains
2023-08-07 Oppenheimer Outperform Outperform Reiterate
2023-10-20 Wells Fargo Equal-Weight Equal-Weight Maintains
2024-04-26 Truist Securities Hold Hold Maintains
2024-02-22 Oppenheimer Outperform Outperform Maintains
2024-04-25 Oppenheimer Outperform Outperform Maintains
2024-03-06 Barclays Equal-Weight Initiate
2024-07-15 Truist Securities Hold Hold Maintains
2024-08-14 UBS Neutral Neutral Maintains
2024-07-30 Wells Fargo Equal-Weight Equal-Weight Maintains
2024-10-25 Truist Securities Hold Hold Maintains
2025-04-11 Truist Securities Hold Hold Maintains
2025-07-16 Truist Securities Hold Hold Maintains
2024-11-22 Raymond James Market Perform Underperform Downgrade
2024-07-25 Oppenheimer Outperform Outperform Maintains
2025-02-20 UBS Neutral Neutral Maintains
2025-02-20 Barclays Equal-Weight Equal-Weight Maintains
2024-08-12 RBC Capital Outperform Outperform Reiterate
2024-10-24 Barclays Equal-Weight Equal-Weight Maintains
2025-01-06 Truist Securities Hold Hold Maintains
2024-11-25 Wells Fargo Equal-Weight Underweight Downgrade
2025-03-10 Wells Fargo Underweight Underweight Maintains
2025-05-29 Wells Fargo Underweight Underweight Maintains
2025-07-24 Barclays Equal-Weight Equal-Weight Maintains
2025-07-24 Jefferies Buy Hold Downgrade
2025-04-09 Guggenheim Neutral Initiate
2025-08-14 Wells Fargo Underweight Underweight Maintains
2025-07-25 UBS Neutral Neutral Maintains
2025-07-25 RBC Capital Outperform Outperform Maintains
Revenue Estimates

The forecasted annual revenue of Community Health Systems, Inc. in 2027-12-31 is 14,715MM. )

Understanding a company’s revenue history gives investors a snapshot of its potential growth. Revenue growth is a solid predictor of earnings (or profit) growth. A company that can increase its revenue while keeping its operating costs constant has more available capital to reinvest into its business or return to shareholders through dividends or share buybacks.

However, investors should be careful before investing in a company that is growing revenue but showing declining earnings or is unprofitable. In some cases, this is simply a case of a young company that is still in an early growth phase. But if this is a mature company, it can indicate that other fundamental problems exist.

How to Interpret Revenue Estimates?

Fintel gives you revenue projections for stocks that cover 10 years between 2020 and 2030. Although past performance does not guarantee future results, you can be more confident in your decision to buy or sell a stock when you see a company with revenue that has a track record of increasing its revenue.

Update Frequency: Quarterly

Date Revenue Average Quarterly (MM) Number of Analysts (Quarterly) Revenue Average Annually (MM) Number of Analysts (Annually)
2025-09-30 3,428 2 -- --
2025-12-31 3,559 2 13,636 4
2026-03-31 3,467 2 -- --
2026-06-30 3,477 2 -- --
2026-09-30 3,445 2 -- --
2026-12-31 3,553 2 13,695 4
2027-12-31 -- -- 14,715 1
Earnings Estimates

The forecasted annual earnings of Community Health Systems, Inc. in 2027-12-31 is 0.93 per share.

One part of an analyst’s rating is a profit (i.e., earnings) estimate for the current quarter and/or future quarters. The measurement given is earnings per share (EPS). EPS is a metric that indicates how much a company earned as represented by one share of its stock over a specific period (typically three months).

Earnings per Share Calculation

To understand the earnings per share calculation, you must understand net income. Net income is the amount of money a company has left over after deducting appropriate expenses and taxes from its revenues).

The formula for earnings per share is net income divided by the total number of outstanding shares (i.e., available for purchase). For example:

Company A has a net income of $100 million and forty million outstanding shares. The EPS calculation is as follows:

100,000,000/40,000,000 = $2.50 per share

How to use Earnings Per Share in Stock Analysis

Earnings per share is an essential metric for you to consider when deciding to buy a stock. After all, a company with high earnings per share is productive and generates revenue in excess of its operating costs.

However, it’s not the only metric you should use. Metrics like price-to-earnings and debt-to-equity add additional perspective about a company’s health.

You should also be sure to compare a company’s EPS with a company in its sector. However, when you do, be aware that EPS is different and more important than net profit by itself. You may see a company that has a rising net profit. But if its outstanding shares are also rising, then its EPS might be flat or even edging lower.

Update Frequency: Quarterly

Date EPS Average (Quarterly) Number of Analysts (Quarterly) EPS Average (Annual) Number of Analysts (Annually)
2025-09-30 0.10 2 -- --
2025-12-31 0.21 2 0.21 5
2026-03-31 0.20 2 -- --
2026-06-30 0.33 2 -- --
2026-09-30 0.35 2 -- --
2026-12-31 0.46 2 0.13 5
2027-12-31 -- -- 0.93 1
EBITDA Estimates

The forecasted annual EBITDA of Community Health Systems, Inc. in 2027-12-31 is 1,820MM.

EBIDTA is an acronym that stands for earnings before interest, taxes, depreciation, and amortization. Analysts and investors pay attention to EBITDA because it strips out items that a company must report on its balance sheet but doesn’t significantly impact its business. Here’s an explanation of what that means for each part of the acronym:

Interest: Loan interest and earnings are subject to change based on a company’s financial strategy and, in any event, are not part of its core activities.

Taxes: Taxes are affected by governmental policy that can distort a company’s perceived profitability.

Depreciation: This accounts for the expected depreciation on tangible assets and immaterial goods from company investments. But since these investments may ultimately increase a company’s efficiency and profit potential, they aren’t a good indicator of a company’s current profitability.

Amortization: This shows the gradual writing off of the initial cost of an asset. It differs from depreciation because it is typically used with intangible assets such as intellectual property (e.g., patents, copyrights, etc.)

EBITDA vs. Net Income

Net income is the profit a company has left over after covering its operating expenses. However, net income includes the items that EBITDA excludes. That’s why most analysts prefer EBITDA because it better reflects the health of a company’s core business.

Update Frequency: Quarterly

Date EBITDA Average (MM Quarterly) Number of Analysts (Quarterly) EBITDA Average (MM Annually) Number of Analysts (Annually)
2025-09-30
2025-12-31
2026-03-31
2026-06-30
2026-09-30
2026-12-31
2027-12-31
EBIT Estimates

The forecasted annual EBIT of Community Health Systems, Inc. in 2026-12-31 is 1,320MM.

EBIT is an acronym that stands for earnings before interest and taxes. Analysts use EBIT to measure a company’s performance because it strips out tax expenses and the costs of the capital structure influencing profit. These don’t significantly impact a company’s business.

Interest: Loan interest and earnings are subject to change based on a company’s financial strategy and, in any event, are not part of its core activities.

Taxes: Taxes are affected by governmental policy that can distort a company’s perceived profitability.

NOTE: EBIT is sometimes synonymous with operating income. However, in some cases, operating income doesn’t include gains or losses from non-core activities.

EBIT vs. EBITDA

EBITDA also strips out depreciation and amortization from a company’s earnings:

Depreciation: This accounts for the expected depreciation on tangible assets and immaterial goods from company investments. But since these investments may ultimately increase a company’s efficiency and profit potential, they aren’t a good indicator of a company’s current profitability.

Amortization: This shows the gradual writing off of the initial cost of an asset. It differs from depreciation because it is typically used with intangible assets such as intellectual property (e.g., patents, copyrights, etc.)

Update Frequency: Quarterly

Date EBIT Average (MM Quarterly) Number of Analysts (Quarterly) EBIT Average (MM Annually) Number of Analysts (Annually)
2025-09-30
2025-12-31
2026-03-31
2026-06-30
2026-09-30
2026-12-31
Other Listings
DE:CG5 €2.36
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista